27/02/2026
As life expectancy increases, preventive healthcare after 65 is shifting from routine testing to personalised, clinically guided screening.
In a recent BBusiness Standardarticle, Dr. Monika Prabhakar, Group Head – Lab Operations (National & International Labs), MMetropolis Labs highlights the need to move beyond age-based protocols toward screening guided by individual health status, existing conditions, and risk profiles.
Quality diagnostics play a vital role in enabling timely, relevant screening—supporting early detection while avoiding unnecessary interventions.
At Metropolis Healthcare, we believe preventive care creates the greatest impact when it is personalised, evidence-based, and focused on quality outcomes across every stage of life.
Check out the article for more insights.
Experts explain which health screenings still matter after 65, which are often overused, and how personalised decisions based on health, frailty, and life expectancy can prevent unnecessary harm.